Bionomics Price to Free Cash Flow Ratio 2022-2024 | NEUP
Historical price to free cash flow ratio values for Bionomics (NEUP) since 2022.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Bionomics Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2024-12-26 |
4.45 |
|
0.00 |
| 2024-09-30 |
0.44 |
$-0.82 |
0.00 |
| 2023-09-30 |
2.70 |
$-0.53 |
0.00 |
| 2023-06-30 |
2.20 |
0 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.010B |
$0.000B |
|
Bionomics Limited is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders. Bionomics Limited is based in ADELAIDE, Australia.
|
